JCB logo
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 18 August 2003. doi:10.1083/jcb.200302073
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vindis, C.
Right arrow Articles by Huynh-Do, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vindis, C.
Right arrow Articles by Huynh-Do, U.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2003/8/661 $5.00
The Journal of Cell Biology, Volume 162, Number 4, 661-671

Article

 EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis

Cécile Vindis1, Douglas Pat Cerretti2, Thomas O. Daniel3 and Uyen Huynh-Do1

1 Division of Nephrology and Department of Clinical Research, University of Bern, CH-3010 Bern, Switzerland
2 Amgen, Seattle, WA 98101
3 Vanderbilt University, Nashville, TN 37232

Address correspondence to Uyen Huynh-Do, Division of Nephrology and Department of Clinical Research, University of Bern, CH-3010 Bern, Switzerland. Tel.: 41-31-632 3141. Fax: 41-31-632 4436. email: uyen.huynh-do{at}insel.ch

Eph receptors and their ligands (ephrins) play an important role in axonal guidance, topographic mapping, and angiogenesis. The signaling pathways mediating these activities are starting to emerge and are highly cell- and receptor-type specific. Here we demonstrate that activated EphB1 recruits the adaptor proteins Grb2 and p52Shc and promotes p52Shc and c-Src tyrosine phosphorylation as well as MAPK/extracellular signal–regulated kinase (ERK) activation. EphB1-mediated increase of cell migration was abrogated by the MEK inhibitor PD98059 and Src inhibitor PP2. In contrast, cell adhesion, which we previously showed to be c-jun NH2-terminal kinase (JNK) dependent, was unaffected by ERK1/2 and Src inhibition. Expression of dominant-negative c-Src significantly reduced EphB1-dependent ERK1/2 activation and chemotaxis. Site-directed mutagenesis experiments demonstrate that tyrosines 600 and 778 of EphB1 are required for its interaction with c-Src and p52Shc. Furthermore, phosphorylation of p52Shc by c-Src is essential for its recruitment to EphB1 signaling complexes through its phosphotyrosine binding domain. Together these findings highlight a new aspect of EphB1 signaling, whereby the concerted action of c-Src and p52Shc activates MAPK/ERK and regulates events involved in cell motility.

Key Words: Eph receptor; MAPK; Src kinase; p52Shc; chemotaxis

The online version of this article includes supplemental material.

Abbreviations used in this paper: ERK, extracellular signal–regulated kinase; HRMEC, human renal microvascular endothelial cell; JNK, c-jun NH2-terminal kinase; PTB, phosphotyrosine binding; RTK, receptor tyrosine kinase; SFK, Src family kinase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents